Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study

BACKGROUND: Biologically naïve patients with inflammatory bowel disease treated with vedolizumab (VDZ) are largely underrepresented in real-world cohorts. A multi-centre, observational cohort study was performed on the effectiveness and safety of VDZ in biologically naïve subjects with Crohn’s disea...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:United European Gastroenterol J
Main Authors: Macaluso, Fabio Salvatore, Fries, Walter, Renna, Sara, Viola, Anna, Muscianisi, Marco, Cappello, Maria, Guida, Laura, Siringo, Sebastiano, Camilleri, Salvatore, Garufi, Serena, Privitera, Antonino Carlo, Belluardo, Nunzio, Giangreco, Emiliano, Bertolami, Carmelo, Vassallo, Roberto, Rizzuto, Giulia, Orlando, Rosalba, Ventimiglia, Marco, Orlando, Ambrogio
פורמט: Artigo
שפה:Inglês
יצא לאור: SAGE Publications 2020
נושאים:
Original Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724546/
https://ncbi.nlm.nih.gov/pubmed/32772830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620948802
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים